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Abstracts: The 16th International Congress on Nutrition and Metabolism in Renal Disease 2012 A85explains cardiovascular disease in patients with end stage renal disease. The
purpose of this study was to estimate the association between CRP and both
carotid and femoral IMT in hemodialysis (HD) patients. The present cross-
sectional study is nested in the Sevelamer hydrochloride and ultrasound-
measured femoral and carotid intima media thickness progression in end
stage renal disease (SUMMER) clinical trial. Carotid (common, internal and
bifurcation) and femoral arteries were visualized in B-mode ultrasonography.
CRP was measured in serum. The study cohort included 177 HD patients
(39.5% female, mean age 67.8711.5 years). All measures of both carotid and
femoral IMT were signiﬁcantly, positively associated with CRP. Compared to
subjects without, subjects with PVD, coronary revascularization and
hypertension had signiﬁcantly higher CRP levels. Conversely, subjects treated
with sevelamer hydrochloride had signiﬁcantly lower CRP levels than those
not exposed to this medication. CRP was signiﬁcantly, positively associated
with serum phosphorus, calcium and PTH, and signiﬁcantly inversely
associated with HDL. In conclusion, CRP is signiﬁcantly, positively associated
with both femoral and carotid IMT and suggests an association between
inﬂammation and atherosclerosis in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.592269
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Patients with advanced CKD have impaired walking function that
predisposes them to falls and disability. Deﬁcits in walking function are
traditionally ascribed to declines in physical function. However, walking
impairment in certain clinical populations may also result from a
phenomenon known as cognitive-motor interference. This is characterized
by reductions in motor task performance (e.g., walking speed) when
simultaneously performing a cognitive task, and is termed a dual task cost
(DTC). The purpose of this study was to compare the contribution of
cognitive interference to decrements in walking performance in
hemodialysis patients and healthy controls.
14 hemodialysis patients (10M,4F, age¼48.5þ/-11.8) and 14 age-matched
healthy controls (9M, 5F, age¼48.5þ/- 10.1) participated. Each completed a
walking task in a control and dual task condition. The walking task involved
walking at a comfortable pace 4 times across a 26’GAITRite TM mat. The ﬁrst
2 trials were completed with no cognitive task and the last 2 trials with a
simultaneous task that consisted of generating a modiﬁed word list. Walking
performance was quantiﬁed with normalized gait speed, step length, base of
support, and step time. DTC was determined for each variable as the %
difference in performance between the single task and dual task.
Major metrics of walking function under standard conditions were
impaired by 20-40% in hemodialysis patients vs controls (po0.05 for each.).
In addition, CKD patients had a greater DTC for velocity, cadence, step time
and double support, than the control group (po0.05), and trends for greater
DTC for step length and width (p ¼ 0.07).
These data indicate that walking impairments in hemodialysis patients are
not due exclusively to declines in physical function, but that cognitive-motor
interference also plays a signiﬁcant role. This has signiﬁcant clinical
importance, as therapies designed to improve walking performance and
physical function, such as nutritional and exercise interventions, may need to
be augmented with cognitive training in order to have maximum beneﬁts.
http://dx.doi.org/10.1016/j.krcp.2012.04.593270
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The food industry over the last decade has undergone a major transformation
in the way they manufacture food, often to the detriment of nutritional
paradigms. Two key components are pivotal to many of these changes: salt and
phosphate food additives. Traditional databases of food composition, especially
for processed foods, are no longer relevant. Phosphorus levels in foods aren’t
required to be on labels and are rarely provided. Phosphorus-containing food
additives are widely used in all types of foods, often where they have never
been seen before. It is common practice to relate phosphorus content in foodclosely to protein value. This can only be reliable for unprocessed rawmaterials.
Any processed foods may have phosphorus additives which will not be evident
on the labels and protein is measured by Kjeldahl nitrogen, which falsely
assumes all nitrogen in foods is protein-related. The reality and future
directions of the food industry need to be taken into account when making
nutritional recommendations. The way forward is to understand the challenges
the food industry faces and work with them to elucidate the problems and seek
solutions.
http://dx.doi.org/10.1016/j.krcp.2012.04.594271
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In a major Victorian hospital, dietitians observed that requests tomedical staff
to prescribe nutritional supplements via themedication chart were inefﬁcient.
This led to delays in the deliveryof nutritional recommendations, thus
compromising patients’nutritional status. Lean Methodology was applied to
simplify theordering of patients’ nutritional supplements as medication(NSAM)
by dietitians. A literature review was conducted. Directobservation and value
stream mapping were used to identifyprocess time and wasted time related to
NSAM prescription. Adetailed root cause analysis of identiﬁed issues was
undertaken,followed by the development of an implementation plan.
Thefollowing problems were identiﬁed: ordering process wascomplicated and
not linear, delay in patient receiving NSAM (2.8days, range 0–23 days), and 60%
repeat requests by the dietitian forNSAM. An implementation plan was
developed which included:submission to the Medical Executive Committee to
seekprescribing privileges for dietitians; dietetic competency trainingand
credentialing, communication strategy, development ofprescribing and
administering procedures; and ward education.Dietetic prescribing privileges
were granted, implemented, andevaluation of this change in dietetic practice
undertaken. Inconclusion, application of Lean Methodology enabled dietitians
toclearly examine, in a systematic manner, delays, risks andinefﬁciencies with
our current process of ordering NSAM. It led toa plan of action to improve
quality of care to our patients, includingrenal patients, and reduce waste in our
health care setting by timelyand appropriate commencement of NSAM.
http://dx.doi.org/10.1016/j.krcp.2012.04.595272
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The understanding of intestinal function in chronic kidney disease (CKD)
has been important elements in the clinical management of CKD with
dietary and drug therapy.
Numerous studies have indicated that CKD patients or model rats have
enzymatic abnormalities and impairments of absorptive function in the
small intestine. However, it
has been still unclear how different of the intestinal function in CKD. In this
study, we demonstrated the microarray analysis of global gene expression in
intestine of adenine-induced CKD rat. DNA microarray analysis using
Affymextrix rat gene chip revealed that CKD caused great changes in gene
expression in the rat duodenum: about 400 genes exhibited more than a two-
fold change in expression level. Gene ontology analysis showed that a global
regulation of genes by CKD involved in iron ion binding, alcoholic, organic acid
and lipid metabolism. Furthermore, we foundmarkedly changes of a number of
intestinal transporters gene expression related to iron metabolism. These
results suggest that CKD may alter some nutrient metabolism in the small
intestine by modifying the expression of speciﬁc genes. The intestinal
transcriptome database of CKD might be useful to develop the novel drugs or
functional foods for CKD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.596
